Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rabin Bista, M.B.B.S. [2]
WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.
NOTE: Most over the counter (OTC) are not reviewed and approved by the FDA. However, they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
Histamine dihydrochloride is a OTC granule that is FDA approved for the treatment of symptoms associated with allergic reactions and Helps support healthy respiratory system. Common adverse reactions include breathing difficulties, chills, cough, diarrhoea, flushing, headaches.
There is limited information regarding Off-Label Guideline-Supported Use of Histamine dihydrochloride in adult patients.
There is limited information regarding Off-Label Non–Guideline-Supported Use of Histamine dihydrochloride in adult patients.
Children: Take three granules and follow adult directions.
There is limited information regarding Off-Label Guideline-Supported Use of Histamine dihydrochloride in pediatric patients.
There is limited information regarding Off-Label Non–Guideline-Supported Use of Histamine dihydrochloride in pediatric patients.
breathing difficulties, chills, cough, diarrhoea, flushing, headaches
There is limited information regarding Postmarketing Experience of Histamine dihydrochloride in the drug label.
There is limited information regarding Histamine dihydrochloride Drug Interactions in the drug label.
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Histamine dihydrochloride in women who are pregnant.
There is no FDA guidance on use of Histamine dihydrochloride during labor and delivery.
There is no FDA guidance on the use of Histamine dihydrochloride with respect to nursing mothers.
There is no FDA guidance on the use of Histamine dihydrochloride with respect to pediatric patients.
There is no FDA guidance on the use of Histamine dihydrochloride with respect to geriatric patients.
There is no FDA guidance on the use of Histamine dihydrochloride with respect to specific gender populations.
There is no FDA guidance on the use of Histamine dihydrochloride with respect to specific racial populations.
There is no FDA guidance on the use of Histamine dihydrochloride in patients with renal impairment.
There is no FDA guidance on the use of Histamine dihydrochloride in patients with hepatic impairment.
There is no FDA guidance on the use of Histamine dihydrochloride in women of reproductive potentials and males.
There is no FDA guidance one the use of Histamine dihydrochloride in patients who are immunocompromised.
There is limited information regarding Monitoring of Histamine dihydrochloride in the drug label.
There is limited information regarding IV Compatibility of Histamine dihydrochloride in the drug label.
Histamine dihydrochloride
| |
Systematic (IUPAC) name | |
2-(1H-imidazol-5-yl)ethanamine dihydrochloride | |
Identifiers | |
CAS number | |
ATC code | L03 |
PubChem | |
Chemical data | |
Formula | Template:OrganicBox atomTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox atomTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBoxTemplate:OrganicBox |
Mol. mass | 184.067 g/mol |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status |
Approved for use in the EU (2008) and Israel (2011) |
Routes | Subcutaneous injection |
There is limited information regarding Pharmacodynamics of Histamine dihydrochloride in the drug label.
There is limited information regarding Pharmacokinetics of Histamine dihydrochloride in the drug label.
There is limited information regarding Nonclinical Toxicology of Histamine dihydrochloride in the drug label.
There is limited information regarding Clinical Studies of Histamine dihydrochloride in the drug label.
There is limited information regarding Histamine dihydrochloride Storage in the drug label.
{{#ask: Page Name::Histamine dihydrochloride |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}
UNDA
Do not use if label perforation is broken
Homeopathic Remedy
NDC : 62106-5986-4
HISTAMINUM HYDROCHLORICUM
Histamine hydrochloride
140 granules
Indications
Helps support healthy respiratory system and alleviates symptoms associated with allergic reactions
{{#ask: Label Page::Histamine dihydrochloride |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}
QUESTIONS? 1-888-737-6925.
There is limited information regarding Histamine dihydrochloride Look-Alike Drug Names in the drug label.
The contents of this FDA label are provided by the National Library of Medicine.